Navigation Links
MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Date:8/19/2007

one of at least 29 naturally occurring interleukins in the human body. Overexpression of IL-9 in animal models has been shown to result in many features of asthma, including increased airway inflammation and hyperreactivity. Blocking the actions of IL-9 has been shown to reduce the airway inflammation and increased airway inflammation and increased airway hyperresponsiveness seen in animal models of asthma. MedImmune is conducting research to evaluate the potential to use MAbs targeting IL-9 to treat or prevent symptomatic, moderate-to-severe, persistent asthma.

About Asthma

Asthma is a chronic disease of the airways that may cause wheezing, breathlessness, chest tightness and coughing. According to the U.S. Centers for Disease Control and Prevention (CDC), more than 30 million Americans reported having a history of asthma in 2003, including 9 million children. About 20 million said they currently had asthma. In 2000, the CDC reported that there were more than 10 million asthma-related outpatient visits to private physician offices and hospital clinics. The National Institutes of Health (NIH) have estimated asthma-related healthcare costs in the U.S. at $14 billion annually.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 3,000 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com .


'/>"/>
SOURCE MedImmune, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
11. Malvern initiates European user group meetings for chemical imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, ... its lead product for the orphan condition acromegaly, today ... financing round. Participants in the financing included new investors ... blue chip public investment fund, as well as existing ... Abingworth and ARCH Venture Partners. Chiasma ...
(Date:2/26/2015)... DALLAS , February 27, 2015 ... Review, H2 2014 market research report to its ... the Corneal Ulcers, therapeutic pipeline. The ... information on the therapeutic development for Corneal Ulcers. ... infections that includes bacterial infections, viral infections & ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  Today the ... The psychological and physical side effects of ... that opioid painkillers, such as Vicodin and Oxycontin, are ... "More Americans overdose on prescription painkillers than on heroin ... president and CEO of NSC. "Yet, these medications are ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... HOERSHOLM, Denmark and SAN DIEGO, California, October 28 ... Wedel, MD, FACP Joins as Vice President and Chief,Medical Officer ... - Stuart Mackey, JD joins as ... Development for Proprietary RNA-targeted,Locked Nucleic Acid (LNA) Drug Platform , ...
... Incorporated (Nasdaq: VPHM ) reported today its financial results for ... million in net product sales including $29 million in net sales ... net income reached $20 million; Improved working capital to $358 ... including cash and cash equivalents of $289 million; and ...
Cached Medicine Technology:Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 2Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 12ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 13ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 14ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 15
(Date:2/27/2015)... February 27, 2015 Hispanics develop alcoholic ... between four and 12 years earlier than Whites/Caucasians or ... Davis Health System. , While previous research indicated that ... populations, the new study -- published online in the ... to be the first to pinpoint racial and ethnic ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 OnChip ... (IPD), has introduced miniature, wire bondable, silicon ESD (Electrostatic ... LED markets. The ESD88NP and ... away from sensitive LED and IC products. These ... Varistors (MLV). All devices meet the requirements of ...
(Date:2/27/2015)... 27, 2015 Just a little over ... those suffering from Sjögren’s Syndrome after a new autoantibody ... at the University of Buffalo and Immco Diagnostics, Inc. ... was to develop a new diagnostic test ... of new autoantibodies. Researchers aimed to develop a test ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Today, February 27th, ... KAJ Brothers , along with LXR Organics and ... END IT Campaign to raise awareness and promote prevention, rescue ... statistics provided by the END IT Coalition, slavery is the ... year and exists in 167 countries around the world. Slavery ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Clinovo, ... ClinCapture, its validated Electronic Data Capture (EDC) at the ... California on March 2nd and March 3rd at Booth ... self-service platform and DIY CRF and edit-check builder allowing ... in a matter of days, without any programming experience. ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2
... had published a report on a new way to detect ... Harvard Mental Health Letter, tests of // cognitive function are ... people will develop Alzheimer’s. In one study, more than 80% ... test of delayed word recall developed Alzheimer’s over the next ...
... hospitals, a small increase in the malfunction of the ... especially for patients suffering from acute kidney injury (AKI). ... reported these results in the latest issue of the ... researchers had analyzed data on 9,210 hospitalized patients who ...
... undergoing a revolution with increasing importance being given to ... of resources allocated to research in specific genetic disorders. ... to scientists working in the field of genetics but ... acquired new. One such breakthrough has been the successful ...
... for children who suffer from chronic sinusitis only ... suggests that life after surgery for these children ... is the first-line surgical therapy for chronic rhinosinusitis ... also being performed with increased frequency to treat ...
... Cornell University in New York are under investigation for ... false information on protocols with the US National Institutes ... a university research center. , ,Former researcher at ... the clinic to treat her adult patient’s and alleged ...
... is a wrinkle control cream and a potent neurotoxin, ... The product is derived form a bacteria, Clostridium botulinum, ... to note that this form of neurotoxin is playing ... cells. The research is exploring basic nerve cell function, ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: